The Expected pullback 48% 27/02/2020

This is in my mind a little later than anticipated .
DOW 16,391 ?
maybe 22,197 .............. If less severe .

I assumed late 2018/2019 .   "Close" . But wrong by one year , darn It , Must do besser .
Maybe a minor one unlike 2008 .
Either of the above is possible .

But , even a small one will lead to an opportunity .
Of course Gold will be a great Investment at the moment for safety .
Although one should recall even in 2008/9 Gold went downwards also .
It just led the market back upwards from 2009 - 2011 .

Best of

bbr391

I shall keep a close eye on Market proceedings over the next weeks , with a Pandemic looking a remote / distant possibility . Things may change Ultra quickly .
The Market , at last found It`s reason to plunge


  --------------------------------------------

Must add Altimmune & Inovio to the portfolio . What don`t kill you makes your vaccine .
Best of All under the Influence and one hopes It treats you kindly .

Best of


And more good news ;

Plymouth Meeting, Pennsylvania-based Inovio specializes in developing DNA vaccines and has created products to treat 15 indications. It is the only company to have a phase 2 vaccine for the coronavirus that caused Middle East respiratory syndrome, or MERS. The company was called on to help during the 2016 Zika outbreak and the Ebola outbreak in 2014.

Inovio Chief Executive Dr. J. Joseph Kim told the U.S. Coronavirus Task Force meeting at the White House on Monday that the company designed INO-4800 on Jan. 10 in three hours after the publication of the genetic sequence of the virus.

For daily coverage of COVID-19: Coronavirus update: 92,314 cases, 3,131 deaths, at least 107 sickened in the U.S.

“We immediately began preclinical testing and small-scale manufacture and have already shared robust preclinical data with our public and private partners,” Kim said in a statement. “We plan to begin human clinical trials in the U.S. in April and soon thereafter in China and South Korea, where the outbreak is impacting the most people.”

Maxim analyst Jason McCarthy, Ph.D., said Inovio likely has the best vaccine option for the new illness. The speed with which it developed INO-4800 “is demonstration of the versatility and speed with which Inovio can respond to an ‘emergency’ situation.”

And more good news for Inovio shareholders anyway :) 
POliticians will be quite high on the list of covid 19 attendees . Thus money will be spent like confetti on these companies . In my humble opine.
Best bbr391